The 230,000-square foot Ann Arbor facility closed by Pfizer in 2008, following a $250-million expansion six years earlier, is being scrutinized by owner University of Michigan. The school considers the pill-making and -packaging operation--part of a 2-million-square-foot complex--a potential magnet for public-private partnership. Article